We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Ennis
EBF
$540M
| $689K | ﹤0.01% |
33,798
-1,775
| -5% | -$35.8K |
|
1252
Oshkosh
OSK
$8.95B
| $688K | ﹤0.01% |
7,949
-5,539
| -41% | -$436K |
|
|
EGRX
1253
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $685K | ﹤0.01% |
35,240
-31,839
| -47% | -$755K |
|
1254
Flowers Foods
FLO
$1.3B
| $685K | ﹤0.01% |
27,526
-3,113
| -10% | -$82.5K |
|
|
HTLF
1255
DELISTED
Heartland Financial USA, Inc.
HTLF
| $677K | ﹤0.01% |
24,285
+601
| +3% | +$18.7K |
|
1256
Welltower
WELL
$169B
| $674K | ﹤0.01% |
8,333
+2,972
| +55% | +$229K |
|
1257
Nuvation Bio
NUVB
$2.03B
| $671K | ﹤0.01% |
+372,814
| New | +$634K |
|
1258
Astronics
ATRO
$2.85B
| $669K | ﹤0.01% |
40,396
-6,901
| -15% | -$94.5K |
|
1259
Aflac
AFL
$58.6B
| $666K | ﹤0.01% |
9,544
+2,370
| +33% | +$159K |
|
|
CMLS
1260
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $666K | ﹤0.01% |
162,366
-15,046
| -8% | -$50.6K |
|
1261
National Fuel Gas
NFG
$7.64B
| $662K | ﹤0.01% |
12,880
+124
| +1% | +$6.59K |
|
1262
Textron
TXT
$13.9B
| $661K | ﹤0.01% |
9,769
-1,640
| -14% | -$108K |
|
1263
NextCure
NXTC
$27.6M
| $661K | ﹤0.01% |
30,579
-1,802
| -6% | -$35.5K |
|
1264
Apple Hospitality REIT
APLE
$3.64B
| $657K | ﹤0.01% |
43,451
-183,782
| -81% | -$2.79M |
|
1265
NetApp
NTAP
$37.6B
| $656K | ﹤0.01% |
8,582
-12,816
| -60% | -$866K |
|
|
HOLX
1266
DELISTED
Hologic
HOLX
| $655K | ﹤0.01% |
8,094
-3,839
| -32% | -$314K |
|
1267
ASE Group
ASX
$98.8B
| $655K | ﹤0.01% |
84,039
-3,655
| -4% | -$28.1K |
|
1268
Boston Beer
SAM
$1.75B
| $654K | ﹤0.01% |
2,120
+270
| +15% | +$86.8K |
|
|
1269
Clorox
CLX
$10.3B
| $648K | ﹤0.01% |
4,074
-1,422,461
| -100% | -$229M |
|
|
ALEX
1270
DELISTED
Alexander & Baldwin
ALEX
| $646K | ﹤0.01% |
34,765
-78
| -0.2% | -$1.46K |
|
|
SYNH
1271
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $646K | ﹤0.01% |
15,323
-649,660
| -98% | -$26.3M |
|
1272
Evercore
EVR
$10.1B
| $644K | ﹤0.01% |
5,211
-159
| -3% | -$18.3K |
|
1273
Puma Biotechnology
PBYI
$485M
| $642K | ﹤0.01% |
181,941
-9,122
| -5% | -$28.5K |
|
1274
United Parks & Resorts
PRKS
$1.64B
| $640K | ﹤0.01% |
11,429
+5,925
| +108% | +$334K |
|
|
HTBK
1275
DELISTED
Heritage Commerce
HTBK
| $637K | ﹤0.01% |
76,902
-2,210
| -3% | -$17.5K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.